✦ LIBER ✦

P.2.c.038 Duloxetine versus placebo in patients with major depressive disorder (MDD): assessment of energy and vitality in MDD

✍ Scribed by T.M. Myers-Oakes; M.E. Thase; A.L. Meyers; J. Ahl; A. Prakash; L.B. Marangell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.c.032 Adjunctive aripiprazole in maj

✍ J.C. Nelson; M.E. Thase; R.A. Baker; L.M. Rollin; R.D. McQuade; R.N. Marcus; R.M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

P.2.g.008 Extended release quetiapine fu

✍ C. Datto; R.W. Lam; U. Lepola; D. Sweitzer; H. Eriksson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

P.2.f.022 Efficacy of 3 agomelatine dose

✍ Kennedy, S.H.; Avedisova, A.; Picarel-Blanchot, F.; De Bodinat, C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

PMH49 COST-EFFECTIVENESS OF ATYPICAL ANT

✍ C Taneja; G Oster; Y Jing; RA Baker; RA Forbes; GI Papakostas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

P.2.b.029 Levomilnacipran SR efficacy in

✍ Montgomery, S.; Gommoll, C.; Chen, C.; Greenberg, W.M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

PMH25 An Assessement of the Cost-Effecti

✍ S. Druais; A. Gauthier; K. Demyttenaere; M. Brignone; A. De Pauw; G. Defraigne; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB